Schneider-Gold, C., Reinacher-Schick, A., Ellrichmann, G., & Gold, R. (2017). Bortezomib in severe MuSK-antibody positive myasthenia gravis: First clinical experience. Ther Adv Neurol Disord.
Stile di citazione ChicagoSchneider-Gold, Christiane, Anke Reinacher-Schick, Gisa Ellrichmann, e Ralf Gold. "Bortezomib in Severe MuSK-antibody Positive Myasthenia Gravis: First Clinical Experience." Ther Adv Neurol Disord 2017.
Citazione MLASchneider-Gold, Christiane, Anke Reinacher-Schick, Gisa Ellrichmann, e Ralf Gold. "Bortezomib in Severe MuSK-antibody Positive Myasthenia Gravis: First Clinical Experience." Ther Adv Neurol Disord 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.